BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 35156574)

  • 21. G-quadruplex structures and their interaction diversity with ligands.
    Zhang S; Wu Y; Zhang W
    ChemMedChem; 2014 May; 9(5):899-911. PubMed ID: 24729465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Crossroads of telomere biology and anticancer drug discovery.
    Seimiya H
    Cancer Sci; 2020 Sep; 111(9):3089-3099. PubMed ID: 32579791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Affinity Chromatography-Based Assays for the Screening of Potential Ligands Selective for G-Quadruplex Structures.
    Platella C; Napolitano E; Riccardi C; Musumeci D; Montesarchio D
    ChemistryOpen; 2022 May; 11(5):e202200090. PubMed ID: 35608081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dimeric aryl-substituted imidazoles may inhibit ALT cancer by targeting the multimeric G-quadruplex in telomere.
    Hu MH; Lin XT; Liu B; Tan JH
    Eur J Med Chem; 2020 Jan; 186():111891. PubMed ID: 31759730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand Selectivity by Inserting GCGC-Tetrads into G-Quadruplex Structures.
    Cao Y; Yang L; Ding P; Li W; Pei R
    Chemistry; 2020 Nov; 26(64):14730-14737. PubMed ID: 32839998
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bisindolylmaleimide Ligands Stabilize
    Kumar S; Reddy Sannapureddi RK; Todankar CS; Ramanathan R; Biswas A; Sathyamoorthy B; Pradeepkumar PI
    Biochemistry; 2022 Jun; 61(11):1064-1076. PubMed ID: 35584037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of G-quadruplexes with nonintercalating duplex-DNA minor groove binding ligands.
    Jain AK; Bhattacharya S
    Bioconjug Chem; 2011 Dec; 22(12):2355-68. PubMed ID: 22074555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural basis for telomeric G-quadruplex targeting by naphthalene diimide ligands.
    Collie GW; Promontorio R; Hampel SM; Micco M; Neidle S; Parkinson GN
    J Am Chem Soc; 2012 Feb; 134(5):2723-31. PubMed ID: 22280460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting unimolecular G-quadruplex nucleic acids: a new paradigm for the drug discovery?
    Parrotta L; Ortuso F; Moraca F; Rocca R; Costa G; Alcaro S; Artese A
    Expert Opin Drug Discov; 2014 Oct; 9(10):1167-87. PubMed ID: 25109710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of an Analogue of the Marine ε-PLL Peptide as a Ligand of G-quadruplex DNA Structures.
    Marzano M; Falanga AP; Marasco D; Borbone N; D'Errico S; Piccialli G; Roviello GN; Oliviero G
    Mar Drugs; 2020 Jan; 18(1):. PubMed ID: 31940851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does ligand symmetry play a role in the stabilization of DNA G-quadruplex host-guest complexes?
    Lauria A; Terenzi A; Bartolotta R; Bonsignore R; Perricone U; Tutone M; Martorana A; Barone G; Almerico AM
    Curr Med Chem; 2014; 21(23):2665-90. PubMed ID: 24533802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting of Telomeric Repeat-Containing RNA G-Quadruplexes: From Screening to Biophysical and Biological Characterization of a New Hit Compound.
    Marzano S; Pagano B; Iaccarino N; Di Porzio A; De Tito S; Vertecchi E; Salvati E; Randazzo A; Amato J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. G-quadruplex, Friend or Foe: The Role of the G-quartet in Anticancer Strategies.
    Carvalho J; Mergny JL; Salgado GF; Queiroz JA; Cruz C
    Trends Mol Med; 2020 Sep; 26(9):848-861. PubMed ID: 32467069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Affinity and selectivity of G4 ligands measured by FRET.
    De Cian A; Guittat L; Shin-ya K; Riou JF; Mergny JL
    Nucleic Acids Symp Ser (Oxf); 2005; (49):235-6. PubMed ID: 17150720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interface of G-quadruplex with both stabilizing and destabilizing ligands for targeting various diseases.
    Chaudhary S; Kumar M; Kaushik M
    Int J Biol Macromol; 2022 Oct; 219():414-427. PubMed ID: 35940429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ligand-induced conformational preorganization of loops of c-MYC G-quadruplex DNA and its implications in structure-specific drug design.
    Harikrishna S; Kotaru S; Pradeepkumar PI
    Mol Biosyst; 2017 Jul; 13(8):1458-1468. PubMed ID: 28650023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stabilization and fluorescence light-up of G-quadruplex nucleic acids using indolyl-quinolinium based probes.
    Biswas A; Singh SB; Todankar CS; Sudhakar S; Pany SPP; Pradeepkumar PI
    Phys Chem Chem Phys; 2022 Mar; 24(10):6238-6255. PubMed ID: 35229834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detecting G4 unwinding.
    Juranek S; Paeschke K
    Methods Enzymol; 2022; 672():261-281. PubMed ID: 35934478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules.
    Francisco AP; Paulo A
    Curr Med Chem; 2017; 24(42):4873-4904. PubMed ID: 27573064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and Telomeric G-Quadruplex-Stabilizing Ability of Macrocyclic Hexaoxazoles Bearing Three Side Chains.
    Ma Y; Iida K; Sasaki S; Hirokawa T; Heddi B; Phan AT; Nagasawa K
    Molecules; 2019 Jan; 24(2):. PubMed ID: 30642002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.